Paracetamol (Acetaminophen): Uses, Dosage, Side Effects and Overdose Explained

Paracetamol (acetaminophen) is the best-selling over-the-counter medicine in the world. It is sold under many brand names — in the United States as Tylenol, across the UK and Commonwealth as Panadol, and in countless generic formulations. It is the first drug most people reach for to treat fever and mild pain, and it is the only analgesic that can be taken during pregnancy with relative safety. Yet despite its apparent harmlessness, it carries one of the most important lessons in pharmacology: the line between a therapeutic dose and a toxic dose can be thin, and many patients are unaware of it.

What is paracetamol (acetaminophen)?

Paracetamol — known in the United States as acetaminophen — is an analgesic and antipyretic that does not belong to the NSAID class (non-steroidal anti-inflammatory drugs). This distinction is fundamental: it relieves pain and lowers fever, but it has no clinically relevant peripheral anti-inflammatory activity. It was first synthesized in 1877, approved as a medicine in the 1950s, and is now included on the World Health Organization (WHO) list of essential medicines.

Unlike NSAIDs such as ibuprofen, paracetamol does not inhibit gastric COX-1, does not reduce the prostaglandins that protect the gastric mucosa, and does not impair platelet function. This gastrointestinal safety profile makes it the analgesic of choice in patients with a history of peptic ulcer, in those on anticoagulant therapy, or in those with chronic kidney disease, when an analgesic is required.

How does paracetamol work?

The mechanism of action of paracetamol has long been debated and is more complex than once believed. It acts mainly at the central level through inhibition of COX-2 in the central nervous system (CNS), where prostaglandins contribute to pain perception and to body-temperature regulation in the hypothalamus. This explains its efficacy as an analgesic and antipyretic without significant peripheral anti-inflammatory effects.

A second mechanism involves the active metabolite AM404, produced in the CNS by the deacetylation of arachidonoyl ethanolamide. AM404 acts on the endocannabinoid system and on TRPV1 receptors (transient receptor potential vanilloid 1), modulating pain-signal transmission at the spinal and supraspinal level. This second mechanism explains why paracetamol has an analgesic effect that goes beyond simple central COX inhibition.

The practical result is effective central analgesia for mild-to-moderate pain, without the gastrointestinal consequences typical of NSAIDs and without the antiplatelet effect of aspirin.

What is paracetamol used for?

Paracetamol is indicated for mild-to-moderate pain of any origin: tension headache, dental pain, menstrual pain, muscle aches from a cold or the flu, minor post-traumatic pain, and early-stage osteoarthritis pain. It is also effective as an antipyretic in every age group, from infants to the elderly.

Paracetamol for fever

It lowers fever by acting on the hypothalamus, reducing the thermal set point raised by the inflammatory response. The recommended threshold for drug treatment is 38.5°C (101.3°F) in children (when there is significant discomfort) and 38°C (100.4°F) in symptomatic adults. The antipyretic effect begins within 30–60 minutes of oral intake and lasts 4–6 hours.

It is neither necessary nor recommended to bring a fever below 37.5°C (99.5°F): a moderate fever is a physiological defensive response — it accelerates immune processes and creates an unfavorable environment for pathogens. Suppressing it completely in the first 24 hours of an infection has no demonstrated benefit in most cases, although symptom relief is a legitimate reason to treat it.

Paracetamol for pain

It is the first-step drug on the WHO analgesic ladder. For chronic pain from mild-to-moderate osteoarthritis, international guidelines (ACR, EULAR) consider it the first pharmacological option, particularly in the elderly or in those with gastrointestinal or cardiovascular contraindications to NSAIDs.

For neuropathic pain (from diabetes, shingles, chemotherapy), paracetamol has limited efficacy — in these cases, gabapentinoids, tricyclic antidepressants, or SNRIs are preferable. For cancer pain, it is the first step of the WHO ladder and remains an integral part of multimodal regimens even when higher steps are added.

In moderate-to-severe pain, paracetamol is not sufficient on its own, but it is optimal in combination: paired with an NSAID it produces synergistic effects through complementary mechanisms; paired with an opioid it reduces opioid consumption by 20–30%, with better pain control and less sedation.

In anesthesia practice, intravenous paracetamol (1 g in 100 mL) is the first step of multimodal post-operative analgesia. The most common error is to give it "as needed" rather than at fixed times during the first 48 hours: scheduled administration maintains constant plasma levels and reduces opioid consumption by 20–30%, with less post-operative nausea and faster recovery.

Paracetamol dosage

Group	Single dose	Interval	Max dose/day	Formulation
Adult	500–1000 mg	Every 4–6 h	3 g (4 g under medical supervision)	Tablets, sachets, IV
Child 6–12 years	15 mg/kg	Every 4–6 h	60 mg/kg/day	Syrup, tablets
Child 1–6 years	15 mg/kg	Every 4–6 h	60 mg/kg/day	Drops, syrup
Infant 3–12 months	15 mg/kg	Every 6–8 h	60 mg/kg/day	Suppositories, drops

The correct dose for a child is always calculated by weight, not by age: 15 mg/kg per dose, not exceeding 60 mg/kg in 24 hours. For a 10 kg child: 150 mg per dose, a maximum of 600 mg in 24 hours. The intravenous route in hospital is indicated when the oral route is unavailable: the intravenous dose in adults is 1 g every 6 hours, infused over 15 minutes.

The general principle is to take the lowest effective dose for the shortest necessary time. The habit of using it "preventively" or at high doses for long periods increases the risk of subclinical liver toxicity, especially in patients with risk factors.

Side effects of paracetamol

At therapeutic doses in healthy people, paracetamol is one of the best-tolerated drugs of all: it does not cause gastric irritation or dyspepsia, it does not affect coagulation or platelet function, and it does not damage the kidneys under normal conditions. The clinically relevant side effect is dose-dependent hepatotoxicity (liver toxicity).

The mechanism of hepatotoxicity

Under normal conditions, about 90% of paracetamol is metabolized through hepatic glucuronidation and sulfation into non-toxic products. The remaining 10% is oxidized by CYP2E1 and CYP3A4 to form NAPQI (N-acetyl-para-benzoquinone imine), a highly reactive metabolite that under normal conditions is immediately neutralized by intracellular glutathione.

The problem arises when the NAPQI produced exceeds the capacity for neutralization: glutathione is depleted and NAPQI binds covalently to hepatocyte proteins, causing centrilobular hepatocellular necrosis. The factors that lower the toxicity threshold are: chronic alcohol consumption (induces CYP2E1, increasing NAPQI production), malnutrition and prolonged fasting (reduce glutathione reserves), enzyme-inducing drugs (rifampicin, phenytoin, carbamazepine), and pre-existing liver disease.

Contraindications and interactions

Severe liver disease is the main contraindication: reduce the maximum dose to 2 g/day under medical supervision. Contrary to what many believe, paracetamol is not contraindicated in mild-to-moderate renal impairment — it is in fact the preferred analgesic in these patients, provided the recommended doses are not exceeded.

Relevant interactions include: warfarin (repeated paracetamol doses ≥2 g/day potentiate the anticoagulant effect — monitor the INR during the first weeks); rifampicin, phenytoin, carbamazepine (accelerate metabolism, reducing efficacy and increasing NAPQI production); alcohol (hepatotoxic synergism — the combination significantly lowers the toxicity threshold).

Liver impairment is the most underestimated contraindication in everyday practice. Before prescribing paracetamol long term, clinicians should always check the transaminases, especially in patients on statins, antiretroviral drugs, or anticonvulsants. A patient with ALT three times the upper limit should not take the standard dose.

Paracetamol overdose

Paracetamol overdose is the leading cause of acute liver failure in Western countries, both in cases of deliberate ingestion (suicide attempt) and unintentional ingestion — dosing errors, combination products not recognized as containing paracetamol (many cold remedies, combination analgesics, nighttime sedatives).

The acute toxicity threshold is about 150 mg/kg as a single dose in a healthy adult, but it drops significantly in people with risk factors. Poisoning unfolds in four well-defined clinical phases. Phase 1 (0–24 hours) is almost asymptomatic — at most nausea and nonspecific malaise — paradoxically the most dangerous phase because liver damage is developing silently. Phase 2 (24–72 hours) shows a rise in transaminases (AST, ALT) with possible right upper-quadrant pain. Phase 3 (72–96 hours) is the moment of maximum liver damage: coagulopathy with elevated INR, jaundice, hepatic encephalopathy. Phase 4 leads to resolution in cases treated promptly, or to fulminant liver failure in severe untreated cases.

The antidote N-acetylcysteine (NAC) works excellently if given within 8 hours of ingestion: it replenishes glutathione reserves and prevents NAPQI from binding to liver proteins. If overdose is suspected, never wait for symptoms — contact a poison control center immediately: the golden window is the first 8 hours.

Frequently asked questions

Can I take paracetamol on an empty stomach?

Yes. It does not irritate the gastric mucosa, unlike NSAIDs. It can be taken at any time relative to meals. This is one of its main practical advantages over ibuprofen, which should be taken with food.

Are Tylenol, Panadol, and paracetamol the same thing?

Yes. Tylenol and Panadol are among the most common brand names for paracetamol (acetaminophen). The active ingredient is identical across all formulations — only the excipients, the galenic formulation, and the price differ.

Can I take paracetamol during pregnancy?

It is the first-choice analgesic during pregnancy (FDA category B). Large-scale studies show no increase in congenital malformations. The precautionary principle is nonetheless to use the lowest effective dose for the shortest necessary time.

How often can I take paracetamol?

500–1,000 mg every 4–6 hours, not exceeding 3 g in 24 hours without a prescription. Be careful with combination products — cold remedies, combination painkillers, OTC sleep aids — that contain paracetamol: it is easy to exceed the maximum dose by adding up several products.

Is paracetamol an anti-inflammatory?

No. It is an analgesic and antipyretic with no clinically relevant peripheral anti-inflammatory activity. It is not effective for acute tendinitis, acute-phase arthritis, or bursitis, where inflammation is the main mechanism of pain. In these conditions an NSAID such as ibuprofen is preferable.

Can paracetamol and ibuprofen be alternated?

Yes, and in pediatrics this is a validated strategy for managing persistent fever: different mechanisms, no dangerous interaction, and more continuous antipyretic coverage while reducing the total dose of each drug.

Paracetamol in the post-operative period and in intensive care

In hospital clinical practice, intravenous paracetamol (1 g/100 mL) plays a central role in multimodal post-operative analgesia. Scheduled administration every 6 hours — not "as needed" — maintains constant plasma levels and reduces opioid consumption by 20–30%, with a consequent reduction in nausea, sedation, and opioid-related respiratory problems. This "opioid-sparing" approach is considered standard in ERAS (Enhanced Recovery After Surgery) guidelines.

In intensive care, paracetamol is the first-choice antipyretic in critically ill patients — preferred over ibuprofen for the absence of significant hemodynamic effects (NSAIDs can interfere with the regulation of renal blood flow) and for the availability of the intravenous formulation.

Paracetamol in special populations

Older adults: paracetamol is the recommended first-choice analgesic in the elderly, precisely because of the absence of gastrointestinal, cardiovascular, and renal effects. The dose should be reduced in people with low body weight (<50 kg) or with reduced liver function: a maximum of 2 g/day in patients with mild-to-moderate liver disease.

Children: the pediatric formulation (syrup, suppositories, drops) is the safest for managing fever and mild pain. The dose is calculated strictly by weight (15 mg/kg), not by age. Excessive use (for example, at every modest temperature rise) should be discouraged — there is no evidence that "keeping the fever down" at all costs improves the outcome in common infections.

Pregnancy and breastfeeding: it is the only analgesic approved for use during pregnancy. The amount passing into breast milk is minimal (about 3% of the maternal dose) — it is not contraindicated during breastfeeding.

Combination products: beware of double exposure

An underestimated problem is the presence of paracetamol in numerous OTC combination products: cold and flu remedies, cough preparations, combination analgesics, and OTC sleep aids (which often contain diphenhydramine plus paracetamol). It is easy to exceed the maximum dose of 3–4 g/day without realizing it when taking several different products at the same time.

The practical rule: always check the composition of every OTC product taken and add up all sources of paracetamol before deciding the dose of the single drug.

Paracetamol and back pain: what the research says

For years, paracetamol was recommended as the first choice for acute and chronic nonspecific back pain. A major randomized Australian trial (Machado et al., BMJ 2015) called this recommendation into question: paracetamol was not significantly more effective than placebo for acute nonspecific low back pain, nor did it speed recovery. This led some guidelines to revise its position in the treatment of simple back pain, while keeping it as an option in cases where NSAIDs are contraindicated.

Paracetamol vs ibuprofen: a practical guide to choosing

The most common question is: "Should I take paracetamol or ibuprofen?" The answer depends on three variables: the type of pain, the presence of particular conditions, and the medications already in use.

Choose paracetamol when: the pain has no clearly identifiable inflammatory component (common tension headache, mild dental pain, generalized malaise from the flu), the patient is elderly with a history of ulcer, the patient takes anticoagulants (warfarin, DOACs), there is chronic kidney disease, the patient is pregnant, the patient is a child under 3 months, or the patient has had a recent heart attack or stroke.

Choose ibuprofen when: the pain has an inflammatory component (tendinitis, sprain, acute arthritis, menstrual pain), the patient is young without gastric problems, the fever requires longer coverage (ibuprofen lasts 6–8 hours vs 4–6 hours for paracetamol), or an anti-inflammatory effect is wanted in addition to analgesia.

Alternating the two: a valid strategy in pediatrics for stubborn fever — different mechanisms, no interaction, more continuous coverage while reducing the total dose of each.

Paracetamol in the chronic treatment of osteoarthritis pain

Osteoarthritis is the most common joint disease and one of the main reasons for chronic paracetamol prescription. The ACR (American College of Rheumatology) and EULAR guidelines recommend paracetamol as a first-line option for symptomatic analgesia, especially in elderly patients with risk factors for NSAIDs.

However, the efficacy of paracetamol in osteoarthritis was called into question by a 2016 Cochrane meta-analysis (Machado et al.) that showed statistically significant but clinically modest benefits — a pain reduction of about 4 points on a 0–100 scale compared with placebo. For many patients, paracetamol reduces pain enough to maintain daily function; for others, NSAIDs or therapy with weak opioids are necessary.

Drugs that contain paracetamol: the hidden list

Paracetamol is present as a component in dozens of OTC and prescription products. The lack of awareness of this "hidden presence" is one of the main causes of accidental overdose.

OTC products with paracetamol: cold and flu remedies (such as hot-drink sachets and "complex" formulations), some decongestant combinations, certain effervescent tablets, and combination painkillers that pair paracetamol with an NSAID.

Prescription drugs with paracetamol: tramadol plus paracetamol, codeine plus paracetamol (various formulations), and other codeine-based combinations.

The practical rule: always read the composition of every product taken, add up all sources of paracetamol, and never exceed 3 g/day when self-medicating or 4 g/day under medical supervision.

The liver test before prolonged prescription

In outpatient practice, before prescribing chronic paracetamol (for example, as a background analgesic for osteoarthritis) to patients with hepatic risk factors, it is good practice to check the transaminases (ALT, AST). It is not an absolute rule, but it helps identify patients with subclinical liver disease (for example, silent steatohepatitis) in whom the maximum paracetamol dose should be reduced to 2 g/day.

This approach is particularly important in patients on statins (a modest additive hepatotoxic effect), metformin (hepatoprotective but does not protect against exogenous toxicity), antiretroviral drugs, systemic azole antifungals, and antiepileptic drugs (carbamazepine, phenytoin — they induce CYP and increase NAPQI production).

Paracetamol in the emergency department: the right questions to ask

When a patient arrives at the emergency department (ED) with suspected paracetamol poisoning, the history must include: the total dose taken (in grams), the time of ingestion, the formulation (standard tablets, modified-release, combination), and the intake of other hepatotoxic drugs or of alcohol. Serum paracetamol measurement is reliable only from 4 hours after ingestion — before then, the drug has not reached its plasma peak.

The Rumack-Matthew nomogram (developed in the 1970s and still in use) makes it possible to assess, based on the serum concentration at 4+ hours after ingestion, the risk of hepatotoxicity and the indication for N-acetylcysteine. It is accessible online and in every ED.

Intravenous N-acetylcysteine is the standard treatment: the SNAP regimen (300 mg/kg over 21 hours) or the traditional three-bag regimen. Efficacy is greatest if given within 8 hours, but it is also useful beyond 8 hours in severe cases.

Use of paracetamol in athletes

Professional athletes often turn to paracetamol to manage training pain and muscle microtears. A controversial point: some studies suggest that paracetamol, taken immediately before or during physical activity, may reduce the post-exercise adaptive response (delayed-onset muscle soreness — DOMS — is partly mediated by prostaglandins and plays a role in the signaling for muscle hypertrophy).

In practice: for acute post-traumatic pain in sport, paracetamol is appropriate. Taken routinely "preventively" before training — a practice seen in some athletes — it has no justification and may interfere with muscle adaptation.

Paracetamol and rebound headache

Like all analgesics, paracetamol can cause medication-overuse headache (MOH) if used too frequently for headache. The threshold is 15 or more days of use per month for at least 3 consecutive months. The paradoxical result is a chronic daily headache, often more intense and harder to manage than the original headache. Treatment requires withdrawal of the causative drug, with specialist neurological support.

Paracetamol and the liver: monitoring in chronic therapy

In patients who take paracetamol regularly (for example, 2 g/day for chronic osteoarthritis pain), monitoring the transaminases (ALT, AST) every 6–12 months is good clinical practice, especially in the presence of hepatic risk factors: known fatty liver, regular alcohol consumption, therapy with hepatotoxic drugs, or high BMI. ALT levels persistently above 3 times the normal value are a signal to reduce the dose or reassess the therapy.

Paracetamol in patients with chronic liver disease

The presence of liver disease is not an absolute contraindication to paracetamol — rather a reason to use the lowest effective dose with greater care. Compensated liver cirrhosis (Child-Pugh A) does not require a drastic dose reduction, but the recommended maximum dose is 2 g/day instead of the 3–4 g for a healthy adult. Decompensated cirrhosis (Child-Pugh C) requires even lower doses and close monitoring.

Paradoxically, low-dose paracetamol is preferable to NSAIDs in patients with cirrhosis, because NSAIDs reduce renal blood flow and can precipitate hepatorenal syndrome — a devastating complication of advanced liver disease.

The interaction between paracetamol and warfarin: a special caution

One of the least-known aspects of paracetamol is its interaction with warfarin. Contrary to what one might think, paracetamol at doses ≥2 g/day taken regularly potentiates the anticoagulant effect of warfarin, raising the INR in a dose-dependent way. The mechanism probably involves inhibition of certain vitamin K-dependent factors in the liver.

Practical consequence: patients on warfarin who start treatment with regular paracetamol doses (for example, 1 g three times a day for chronic pain) should measure the INR within 7–10 days of starting therapy. Ibuprofen and other NSAIDs also potentiate warfarin, but through a different mechanism (reduced warfarin metabolism by CYP2C9 and additional platelet inhibition). Paracetamol nonetheless remains safer than NSAIDs for anticoagulated patients, provided the INR is monitored.

Paracetamol and alcohol: a dangerous pair

The combination of paracetamol and alcohol is one of the most frequent causes of iatrogenic acute liver failure, often unintentional. In heavy chronic drinkers, hepatic CYP2E1 is constantly induced by alcohol, increasing the production of NAPQI (the hepatotoxic metabolite) even at "standard" doses of paracetamol. In addition, chronic alcohol consumption depletes hepatic glutathione reserves, reducing the capacity to neutralize the NAPQI produced.

The practical recommendation is not to take more than 2 g/day of paracetamol if you consume more than 3 alcoholic drinks per day. This threshold is much lower than that for a healthy adult. A patient with alcohol dependence who self-medicates a headache with multiple doses of "regular" paracetamol (such as 3–4 sachets of 1 g per day) risks significant liver toxicity.

Pediatric dosing: weight-based dosing tables

Pediatric guidelines recommend paracetamol at a dose of 15 mg/kg per administration, with a minimum interval of 4 hours between doses and a maximum daily dose of 60 mg/kg/day (not exceeding 4 g/day in adolescents). Practical examples for parents: a 10 kg child → 150 mg/dose → one 125 mg sachet or 1.5 sachets of 100 mg; a 20 kg child → 300 mg/dose → one 250 mg sachet or two 125 mg sachets; a 30 kg child → 450 mg/dose → one 500 mg tablet. A parent who uses an age-based table (instead of weight) risks underdosing children who are tall for their age or overdosing smaller children.

Paracetamol is one of the best-documented drugs in modern medicine. Its efficacy in mild-to-moderate pain and as an antipyretic is robustly demonstrated by decades of clinical use and hundreds of randomized trials. Its safety profile, excellent at therapeutic doses in healthy people, requires attention in high-risk situations — liver disease, alcohol consumption, hidden combination products. Knowing these elements makes it possible to use it with awareness, maximizing benefits and minimizing risks.

Paracetamol remains the reference safe choice for fever and mild-to-moderate pain in all age groups. Its efficacy is proven; the risks, real but rare, are manageable with the correct dose. Precise information — about the maximum dose, the hidden combination products, and safe use in liver disease and pregnancy — is the most important contribution a doctor or pharmacist can give to the patient who self-medicates with this drug.

References

• Prescott LF. Paracetamol: past, present, and future. Am J Ther. 2000;7(2):143-147.

• Mazaleuskaya LL, et al. PharmGKB summary: pathways of acetaminophen metabolism at therapeutic versus toxic doses. Pharmacogenet Genomics. 2015;25(8):416-426.

• Graham GG, et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201-232.

• Acetaminophen. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. NIDDK; 2023.